Market Cap (In CNY)
5.54 Billion
Revenue (In CNY)
895.59 Million
Net Income (In CNY)
-8.92 Million
Avg. Volume
16.69 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.03-6.43
- PE
- -
- EPS
- -
- Beta Value
- 0.6
- ISIN
- CNE100000H10
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Rongzhao Qiu
- Employee Count
- -
- Website
- https://www.cqlummy.com
- Ipo Date
- 2009-10-30
- Details
- Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; electrolyte and acid-base products; balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is based in Chongqing, China.
More Stocks
-
6649
-
KINGSINFRKings Infra Ventures Limited
KINGSINFR
-
UAVS
-
EFOIEnergy Focus, Inc.
EFOI
-
ASAGF
-
7738EUI
7738
-
VMRI
-
002145